Thematically, the focus for the next 5 years will be on so-called “subversive technologies” such as genome editing and interdisciplinary fields such as artificial intelligence. Key programs will be on biomedicine, bioresources utilization and highly integrated biosecurity threat defense system. China wants to become a leader in biotechnology by strengthening biotech innovation alliances, e. g., in the Beijing Tianjin Hebei area, in the Yantze River and in the Pearl River Deltas. Strategic resources such as gene centers or strain/tissue collection centers will be built, preferentially in specialized parks within national high-tech parks, and a biotech technology transfer service system aims at a biotech contract turnover of over 100 billion Yuan.
China Bio news release, May 15, 2017